A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor (GRM1) signaling, in advanced melanoma.
暂无分享,去创建一个
James S Goydos | Y. Wen | J. Lee | J. Mehnert | L. Dudek | S. Chen | L. Pruski-Clark | W. Shih
暂无分享,去创建一个
James S Goydos | Y. Wen | J. Lee | J. Mehnert | L. Dudek | S. Chen | L. Pruski-Clark | W. Shih